Company intelligence
Ametris
A Signant Health Company
Biotechnology Research
Pensacola, US
145 employees
2 public signals
About Ametris
At Ametris, we partner with life sciences organizations to transform complex, real-world patient data into evidence that drives progress. Our end-to-end DHT platform integrates advanced wearable technologies, expert scientific consultation, and regulatory-aligned analytics to support every phase of a clinical trial. From initial study design through submission, we simplify digital implementation and ensure that data serves its highest purpose: informing better science and improving lives.
Verified activity
Signals from Ametris
2 published signals
Presence & Recognition
Ametris is hosting a Digital Health Monthly webinar on Thursday, September 24th, 2026, at 12pm-1pm EST to explore wearable-derived physical activity as a digital endpoint in COPD and continuous cough and exacerbation monitoring.
Reported by Ametris
Presence & Recognition
Ametris employee Sean Smith will attend DPharm 2026 in Boston next month.
Reported by Sean Smith